A Phase II Study of Neoadjuvant Sotorasib in Combination With Cisplatin or Carboplatin and Pemetrexed for Surgically Resectable Stage IIA-IIIB Non-Squamous Non-Small Cell Lung Cancer With a KRAS p.G12C Mutation
Clinical trial NCT05118854 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05118854
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-30
- Primary completion
- 2027-10-20
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.